Search Results - Muriel Granier

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Ruxolitinib for essential thrombocythemia refractory to or intolerant of hydroxyurea: long-term phase 2 study results

    Ruxolitinib for essential thrombocythemia refractory to or intolerant of hydroxyurea: long-term phase 2 study results by Srđan Verstovšek, Francesco Passamonti, Alessandro Rambaldi, Giovanni Barosi, Elisa Rumi, Elisabetta Gattoni, Lisa Pieri, Hui‐Ling Zhen, Muriel Granier, Albert Assad, Mario Cazzola, Hagop M. Kantarjian, Tiziano Barbui, Alessandro M. Vannucchi

    Published 2017
    Get full text Get full text
    Carta
    Save to List
    Saved in:
  2. 2
    INCB84344-201: Ponatinib and steroids in frontline therapy for unfit patients with Ph+ acute lymphoblastic leukemia

    INCB84344-201: Ponatinib and steroids in frontline therapy for unfit patients with Ph+ acute lymphoblastic leukemia by Giovanni Martinelli, Cristina Papayannidis, Alfonso Piciocchi, Valentina Robustelli, Simona Soverini, Carolina Terragna, Giovanni Marconi, Roberto M. Lemoli, Fabio Guolo, Antonella Fornaro, Monia Lunghi, Paolo de Fabritiis, Anna Candoni, Carmine Selleri, Federico Simonetti, Monica Bocchia, Antonella Vitale, Luca Frison, Alessandra Tedeschi, Antonio Cuneo, Massimiliano Bonifacio, Maria Paola Martelli, Stefano D’Ardìa, Silvia Trappolini, Patrizia Tosi, Piero Galieni, Francesco Fabbiano, Maria Chiara Abbenante, Muriel Granier, Zhaoyin Zhu, Mingyue Wang, Chiara Sartor, Stefania Paolini, Michèle Cavo, Robin Foà, Paola Fazi, Marco Vignetti, Michele Baccarani

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: